<DOC>
	<DOCNO>NCT01920412</DOCNO>
	<brief_summary>This study mainly evaluate feasibility safety LAmbre Left Atrial Appendage Occluder prevent ischemic stroke cause atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Feasibility Safety Study LAmbre Left Atrial Appendage Occluder</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common arrhythmia , incidence increase age . Thrombosis shed cause AF one major cause stroke . Most patient AF suffer ischemic stroke thrombosis leave atrial appendage ( LAA ) . The majority patient atrial fibrillation , blood clot come leave atrial appendage , close leave atrial appendage reduce cycle thromboembolism patient AF . Now patient cardiac surgery risk leave atrium related thromboembolism , surgery conventional perform leave atrial appendage close surgery . However , surgical leave atrial appendage ligation difficult completely close leave atrial appendage , internal medicine intervention method surgical closure leave atrial appendage relatively simple , minimally invasive , high success rate expect widely use . Several version LAA occlusion device developed.LAA occluder Lifetech consist umbrella , cover conveyor ; The umbrella compose multiple umbrella cover ePTFE membrane.This study mainly evaluate feasibility safety LAmbre Left Atrial Appendage Occluder ! Through femoral vein puncture ; insert inter atrial septum puncture device ; puncture small hole atrial septal , delivery sheath insert femoral vein puncture site across atrial septal reach leave atrial appendage , establishment channel . Through built-channel sent LAA occluder leave atrial appendage delivery cable ; The LAA occlude fix leave atrial appendage , close entrance leave atrial appendage meanwhile block blood flow ; eliminate risk blood clot due atrial fibrillation , prevention stroke .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patient ≥18 year age ; 2 . Chronic atrial fibrillation ≥3 month ; paroxysmal , persistent permanent nonvalvular AF ; 3 . CHADS2VAS score 2 high ; 4 . Patient understand trial purpose , voluntarily join clinical trial informed consent ; 5 . Patient voluntarily complete followup followup inspection accordance clinical trial process . A . Clinical exclusion criterion 1 . Presence rheumatic , degenerative congenital valvular heart disease , 2 . The diameter leave atrial ≥65 mm ; 3 . LAA size &lt; 12mm &gt; 30 mm 4 . Left atrium remove ; 5 . Heart transplantation patient ; 6 . Symptomatic patient carotid artery disease ( carotid stenosis ≥ 50 % ) ; 7 . Acute myocardial infarction unstable angina ; 8 . Decompensated heart failure ( New York Heart Association functional class IIIIV ) ; 9 . Recent myocardial infarction ( &lt; 3 month ) ; 10 . Patients atrial septal defect receive atrial septal occluder . The patient ablation procedure plan within 30 day potential LAmbre Occluder implant 11 . The patient plan cardioversion 30 day post implant LAmbre Occluder 12 . Patient artificial mechanical heart valve replacement operation ; 13 . Uncontrolled Heart rate ≥ 110 beat / min17 ) History stroke TIA within 30 day ; 14 . Presence complex aortic plaque ( 4mm ) ascend aorta ; 15 . Cardiac tumor malignancy estimate life expectancy u less 2 year ; 16 . Have thrombocytopenia ( platelet 《105 / μl ) anemia（Hb &lt; 10g/dl） ; 17 . Women pregnancy plan pregnancy trial period ; 18 . Presence active sepsis endocarditis ; 19 . Patient participate trial ; 20 . The investigator expect patient able complete trial accord requirement . B. Esophageal ultrasonic exclusion criterion 1 . LVEF≤30 % ; 2 . Presence leave atrial appendage thrombus ; 3 . High risk PFO patient ( presence atrial septal aneurysm ) ; 4 . Have obvious mitral valve stenosis ( area mitral valve≤ 2 cm2 ) ; 5 . Have obvious unexplained pericardial effusion ( ≥4 cm2 ) . 6 . Presence complex aortic plague ( ≥4 mm ) ascend aorta .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Left atrial appendage occluder</keyword>
	<keyword>Intervention method</keyword>
</DOC>